EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023)
PROBLEMS of Infectious and Parasitic Diseases · 2025
DOI: 10.58395/03r0mk42 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROBLEMS of Infectious and Parasitic Diseases, 2025. Verfasst von Kim Ngoc und 8 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The COVID-19 pandemic in Bulgaria was characterized by a high mortality rate and vaccination efforts yielded suboptimal results. Understanding population immunity is important as new SARS-CoV-2 variants continue to emerge. This study aimed to assess the seroprevalence of SARS-CoV-2 antibodies in the general population of Bulgaria and examine demographic variations in antibody presence. Materials and methods: In December 2023, 1895 serum samples were randomly collected from healthy individuals across all 28 provinces. Samples were tested for SARS-CoV-2 spike protein-specific IgG antibodies using ELISA method. A subset of the positive samples was subsequently tested for neutralizing antibodies. Seroprevalence was analyzed by sex, age group, and geographic region. Statistical analyses were conducted using SPSS v.26.
Results
Overall seroprevalence was 91.9%, with similar rates between males (91.6%) and females (92.0%). Seroprevalence was highest in the 18-39 age group (95.1%) and lowest in those over 65 (89.3%). Regional seroprevalence ranged from 80.0% to 98.3%. Among samples tested for presence of neutralizing antibodies, 90.5% were positive, indicating effective immune response.
Conclusions
The high seroprevalence suggests widespread prior exposure to SARS-CoV-2 and/or vaccination among the Bulgarian population. The strong presence of neutralizing antibodies might provide potential protection against severe disease. Targeted interventions towards older age groups could be appropriate in order to sustain immunity as COVID-19 remains a public health concern.
Zitieren
APA
Ngoc, K., Trifonova, I., Gladnishka, T., Panayotova, E., Taseva, E., Ivanova, V., Kutevа, E., Vladimirova, I., & Christova, I. (2025). EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023). PROBLEMS of Infectious and Parasitic Diseases. https://doi.org/10.58395/03r0mk42
Vancouver
Ngoc K, Trifonova I, Gladnishka T, Panayotova E, Taseva E, Ivanova V, et al. EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023). PROBLEMS of Infectious and Parasitic Diseases. 2025. doi:10.58395/03r0mk42
BibTeX
@article{Ngoc2025,
author = {Ngoc, Kim and Trifonova, Iva and Gladnishka, Teodora and Panayotova, Elitsa and Taseva, Evgenia and Ivanova, Vladislava and Kutevа, Eleonora and Vladimirova, Iva and Christova, Iva},
title = {EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023)},
journal = {PROBLEMS of Infectious and Parasitic Diseases},
year = {2025},
doi = {10.58395/03r0mk42}
}
EUVIMED